SI2002825T1 - Farmacevtski sestavki, ki obsegajo orlistat - Google Patents
Farmacevtski sestavki, ki obsegajo orlistatInfo
- Publication number
- SI2002825T1 SI2002825T1 SI200731294T SI200731294T SI2002825T1 SI 2002825 T1 SI2002825 T1 SI 2002825T1 SI 200731294 T SI200731294 T SI 200731294T SI 200731294 T SI200731294 T SI 200731294T SI 2002825 T1 SI2002825 T1 SI 2002825T1
- Authority
- SI
- Slovenia
- Prior art keywords
- orlistat
- pharmaceutical compositions
- pharmaceutical
- compositions
- Prior art date
Links
- AHLBNYSZXLDEJQ-FWEHEUNISA-N orlistat Chemical compound CCCCCCCCCCC[C@H](OC(=O)[C@H](CC(C)C)NC=O)C[C@@H]1OC(=O)[C@H]1CCCCCC AHLBNYSZXLDEJQ-FWEHEUNISA-N 0.000 title 1
- 229960001243 orlistat Drugs 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D305/00—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
- C07D305/02—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D305/10—Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms not condensed with other rings having one or more double bonds between ring members or between ring members and non-ring members
- C07D305/12—Beta-lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/365—Lactones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Child & Adolescent Psychology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP07011695.9A EP2002825B1 (en) | 2007-06-14 | 2007-06-14 | Pharmaceutical compositions comprising orlistat |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI2002825T1 true SI2002825T1 (sl) | 2013-10-30 |
Family
ID=38430516
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200731294T SI2002825T1 (sl) | 2007-06-14 | 2007-06-14 | Farmacevtski sestavki, ki obsegajo orlistat |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP2002825B1 (sl) |
| PL (1) | PL2002825T3 (sl) |
| SI (1) | SI2002825T1 (sl) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0901602B8 (pt) * | 2009-04-03 | 2021-05-25 | Ems S/A | formulação farmacêuticas |
| MX342962B (es) * | 2009-09-18 | 2016-06-07 | Teva Pharmaceuticals Holdings Mexico S A De C V | Composicion farmaceutica para bajar de peso y procedimiento para obtener la misma. |
| JP2013147488A (ja) * | 2011-12-21 | 2013-08-01 | Taisho Pharmaceutical Co Ltd | 固形製剤 |
| CN107412176A (zh) * | 2017-05-21 | 2017-12-01 | 天津双硕医药科技有限公司 | 一种含有奥利司他的减肥片剂 |
| CN108440456B (zh) * | 2018-03-22 | 2020-01-03 | 中山万汉制药有限公司 | 奥利司他与有机酸钙的共晶体及包含该共晶体的药物组合物 |
| CN110734420A (zh) * | 2019-12-04 | 2020-01-31 | 重庆植恩药业有限公司 | 一种奥利司他杂质f及其制备方法和用途 |
| CN115105476B (zh) * | 2021-03-23 | 2023-11-14 | 山东新时代药业有限公司 | 一种奥利司他冻干口服制剂及其制备工艺 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW381025B (en) * | 1993-08-05 | 2000-02-01 | Hoffmann La Roche | Pharmaceutical composition containing a glucosidase inhibitor and a lipase inhibitor |
| US6004996A (en) * | 1997-02-05 | 1999-12-21 | Hoffman-La Roche Inc. | Tetrahydrolipstatin containing compositions |
| US6607749B1 (en) * | 1998-09-08 | 2003-08-19 | Smithkline Beecham Corporation | Lipstatin derivative-soluble fiber tablets |
| EP1470116A4 (en) * | 2001-12-04 | 2005-04-06 | Biogal Gyogyszergyar | PREPARATION OF THE ORLISTAT AND CRYSTALLINE FORMS OF THE ORLISTAT |
| WO2005026140A1 (en) * | 2003-09-12 | 2005-03-24 | Ranbaxy Laboratories Limited | Process for the preparation of crystalline forms of orlistat |
| KR100669497B1 (ko) * | 2005-08-17 | 2007-01-16 | 보람제약주식회사 | 안정성과 용출률이 뛰어난 약리학적 조성물 및 그 제조방법 |
| EP1803714A1 (en) * | 2005-12-27 | 2007-07-04 | KRKA, tovarna zdravil, d.d., Novo mesto | Process for preparing crystalline forms of orlistat |
-
2007
- 2007-06-14 EP EP07011695.9A patent/EP2002825B1/en not_active Not-in-force
- 2007-06-14 SI SI200731294T patent/SI2002825T1/sl unknown
- 2007-06-14 PL PL07011695T patent/PL2002825T3/pl unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP2002825B1 (en) | 2013-05-22 |
| PL2002825T3 (pl) | 2013-12-31 |
| EP2002825A1 (en) | 2008-12-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL247741A0 (en) | pharmaceutical preparations | |
| EP2001498A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| IL194176A0 (en) | Pharmaceutical compositions | |
| GB0713625D0 (en) | Pharmaceutical compositions | |
| EP2222313A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| PL2124556T3 (pl) | Kompozycje farmaceutyczne | |
| PL2966175T3 (pl) | Kompozycje farmaceutyczne zawierające 17-alfa-propionian korteksolonu | |
| GB0608724D0 (en) | Novel Pharmaceutical Compositions | |
| EP2146695A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| GB0707127D0 (en) | Pharmaceutical compositions | |
| PL2002825T3 (pl) | Kompozycje farmaceutyczne zawierające orlistat | |
| GB0709811D0 (en) | Pharmaceutical compositions | |
| GB0610322D0 (en) | Novel pharmaceutical compositions | |
| GB0716907D0 (en) | Pharmaceutical powder compositions | |
| GB0712454D0 (en) | Pharmaceutical compositions | |
| GB2454923B (en) | Pharmaceutical compositions | |
| IL201394A0 (en) | Niacin - based pharmaceutical compositions | |
| HU0700755D0 (en) | Pharmaceutical compositions containing capsaicionid | |
| GB0800659D0 (en) | Pharmaceutical Compositions | |
| GB0706657D0 (en) | Pharmaceutical compositions | |
| GB0709603D0 (en) | Pharmaceutical compositions | |
| GB0713794D0 (en) | Novel pharmaceutical compositions | |
| GB0701367D0 (en) | Novel pharmaceutical compositions | |
| GB0704749D0 (en) | Novel pharmaceutical compositions | |
| GB0701364D0 (en) | Novel pharmaceutical compositions |